Overview

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate hyperemia and ocular surface tolerability in patients on prostaglandin analogues
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Latanoprost
Ophthalmic Solutions
Tetrahydrozoline
Travoprost